Mg. Cormican et Rn. Jones, ANTIMICROBIAL ACTIVITY OF CEFOTAXIME TESTED AGAINST INFREQUENTLY ISOLATED PATHOGENIC SPECIES (UNUSUAL PATHOGENS), Diagnostic microbiology and infectious disease, 22(1-2), 1995, pp. 43-48
The cefotaxime sodium spectrum of activity is very broad and includes
many common species and a variety of less frequently isolated pathogen
s. We have reviewed the clinical microbiology literature (44 reference
s) and the data base of the University of Iowa Hospitals and Clinics (
Iowa City, IA) to collect data on the activity of cefotaxime against t
he less common species. Cefotaxime was consistently active against Act
inobacillus actinomycetemcomitans, Capnocytophaga spp., Eikenella corr
odens, Erysipelothrix rhusiopathiae, Pasteurella multocida, Plesiomona
s shigelloides, and Fusobacterium nucleatum. The species Alcaligenes x
ylosoxidans, Flavobacterium spp., Stenotrophomonas (Xanthomonas) malto
philia, Bacillus cereus, Listeria monocytogenes, and Rhodococcus equi
were uniformly cefotaxime resistant. For many other species there was
considerable variation in reported minimum inhibitory concentrations.
These data may be helpful in guiding therapy of unusual infections, pa
rticularly in the case of fastidious species, where the appropriate su
sceptibility testing methodology may not be immediately or routinely a
vailable.